Cargando…

Erratum to: Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial

Detalles Bibliográficos
Autores principales:	Tiono, Alfred B., Diarra, Amidou, Sanon, Souleymane, Nébié, Issa, Konaté, Amadou T., Pagnoni, Franco, Sirima, Sodiomon B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2013
Materias:	Publisher's Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108103/ https://www.ncbi.nlm.nih.gov/pubmed/25134485 http://dx.doi.org/10.1007/s40121-013-0017-3

Ejemplares similares

Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial
por: Tiono, Alfred B., et al.
Publicado: (2013)

Hospital-based surveillance of severe paediatric malaria in two malaria transmission ecological zones of Burkina Faso
por: Tiono, Alfred B., et al.
Publicado: (2023)

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens
por: Tiono, Alfred B, et al.
Publicado: (2009)

Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2012)

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso
por: Soulama, Issiaka, et al.
Publicado: (2015)

Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso
por: Bougouma, Edith C, et al.
Publicado: (2012)

Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2013)

Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso
por: Soulama, Issiaka, et al.
Publicado: (2009)

Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies
por: Gansane, Adama, et al.
Publicado: (2013)

Malariometric Indices in the Context of Seasonal Malaria Chemoprevention in Children Aged 1.5 to 12 Years during the Period of High Malaria Transmission in the Suburban Area of Banfora, Burkina Faso
por: Ouattara, San M., et al.
Publicado: (2023)

Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2014)

Contribution of the Rapid LAMP-Based Diagnostic Test (RLDT) to the Evaluation of Enterotoxigenic Escherichia coli (ETEC) and Shigella in Childhood Diarrhea in the Peri-Urban Area of Ouagadougou, Burkina Faso
por: Héma, Alimatou, et al.
Publicado: (2023)

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso
por: Cherif, Mariama K., et al.
Publicado: (2017)

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
por: Morter, Richard, et al.
Publicado: (2022)

Malaria Incidence in Children in South-West Burkina Faso: Comparison of Active and Passive Case Detection Methods
por: Tiono, Alfred B., et al.
Publicado: (2014)

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2009)

A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age
por: Ouédraogo, Alphonse, et al.
Publicado: (2013)

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum
por: Sirima, Sodiomon B, et al.
Publicado: (2009)

Implementation of Home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2008)

Plasmodium falciparum Malaria in Children Aged 0-2 Years: The Role of Foetal Haemoglobin and Maternal Antibodies to Two Asexual Malaria Vaccine Candidates (MSP3 and GLURP)
por: Kangoye, David Tiga, et al.
Publicado: (2014)

Integrated Community Case Management of Fever in Children under Five Using Rapid Diagnostic Tests and Respiratory Rate Counting: A Multi-Country Cluster Randomized Trial
por: Mukanga, David, et al.
Publicado: (2012)

Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2010)

Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey
por: Yaro, Jean Baptiste, et al.
Publicado: (2021)

Dynamics of malaria transmission and susceptibility to clinical malaria episodes following treatment of Plasmodium falciparum asymptomatic carriers: results of a cluster-randomized study of community-wide screening and treatment, and a parallel entomology study
por: Tiono, Alfred B, et al.
Publicado: (2013)

Morbidity from Malaria in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria: A Randomised Trial
por: Konaté, Amadou T., et al.
Publicado: (2011)

Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial
por: Konaté, Amadou T., et al.
Publicado: (2011)

In vitro antiplasmodial and cytotoxic properties of some medicinal plants from western Burkina Faso
por: Sanon, Souleymane, et al.
Publicado: (2013)

Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
por: Ouédraogo, Alphonse, et al.
Publicado: (2023)

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso
por: Sirima, Sodiomon B., et al.
Publicado: (2021)

Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso
por: NEBIE, I, et al.
Publicado: (2009)

Novel Insights Into the Protective Role of Hemoglobin S and C Against Plasmodium falciparum Parasitemia
por: Mangano, Valentina D., et al.
Publicado: (2015)

Human genetic variation influences Plasmodium falciparum drug resistance selection
por: Paganotti, Giacomo Maria, et al.
Publicado: (2014)

Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children
por: Tiono, Alfred B., et al.
Publicado: (2023)

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
por: Gonçalves, Bronner P., et al.
Publicado: (2016)

A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2013)

Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
por: Adu, Bright, et al.
Publicado: (2016)

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
por: Sirima, Sodiomon B., et al.
Publicado: (2021)

Fulani show decreased susceptibility to Plasmodium falciparum infection versus Mossi: data from a community-wide screening and treatment of asymptomatic carriers in Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6l0oe9ok6okajc5mimi7lcuahl